Trials / Withdrawn
WithdrawnNCT02046551
Atomoxetine's Effects On Nicotine Response And Stress Response In Smokers
- Status
- Withdrawn
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Yale University · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate atomoxetine's effects on the rewarding and reinforcing effects of nicotine in a controlled human laboratory study with 24 otherwise healthy nicotine dependent subjects. It is hypothesized that atomoxetine will attenuate the negative effects of nicotine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Atomoxetine | |
| DRUG | Placebo |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2017-02-01
- Completion
- 2017-02-01
- First posted
- 2014-01-27
- Last updated
- 2017-05-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02046551. Inclusion in this directory is not an endorsement.